The Pivotal Role of Gut Microbiota in Alzheimer's Disease Progression and Prevention

The human gut microbiota, comprised of trillions of microorganisms existing symbiotically within the gastrointestinal tract, plays a vital role in maintaining gut and neurological health by regulating homeostasis through the gut-brain axis. Recent studies have shown that an imbalance or alteration of the composition of gut microbiota, or gut dysbiosis, is linked to the aggregation of Aβ, the development of tau proteins, and the occurrence of neuroinflammation and oxidative stress associated with Alzheimer’s Disease (AD) (Dissanayaka et al., 2024). 

The gut-brain axis refers to the bidirectional communication pathway between the intestinal functions of the enteric nervous system (ENS), and the cognitive functions of the central nervous system (CNS). Through this linkage, the secretion of various neuroactive substances by the gut microbiota, such as neurotransmitters, short-chain fatty acids (SCFAs), and other metabolites are circulated via the lymphatic and systemic circulation throughout the CNS. These substances are generated through the fermentation of dietary fibres and other components by gut bacteria and directly affect behaviour, brain plasticity, and cognitive function. Studies carried out by Bravo and Tillisch et al. demonstrated the dysregulation of the gut-brain axis, and its implication in not only chronic functional GI disorders but depression and decreased cognitive function as well. This linkage thus suggests the importance of the gut microbiota on the pathophysiology of chronic brain diseases such as AD and has become a potential target for therapeutic interventions aimed at enhancing brain health. 

Giau et al.'s research revealed that immuno-inflammatory control regulation is one of the important mechanisms involved in the cause of AD. Depending on how gut microbiota is affected, inflammatory responses which are crucial for neurodegenerative diseases may either improve or worsen brain health. As a result, they can either hasten or prevent the onset of AD. Pro-inflammatory dysbiosis within the gut microbiota of AD patients has been identified as a catalyst for inflammation-induced formation and aggregation of cerebral Aβ, a hallmark of AD (Giau et al., 2018). Certain bacterial strains such as Escherichia coli and Salmonella enterica can generate extracellular amyloid fibers that may support Aβ aggregation in the brain and therefore contribute to AD pathogenesis. The microbial effects go beyond direct interaction with amyloid proteins, but they also encompass wider activation of immune responses within the CNS involving neuroinflammation by microglia and astrocytes which also influence AD progression (Giau et al., 2018). 

Nevertheless, the gut microbiota has a potential role in preventing AD. Some studies have revealed that certain types of microbes in the gut decrease the chances of developing AD (Giau et al., 2018). For example, germ-free mice or those with altered gut microbiota display different levels of Aβ plaque formation and neuroinflammation, making it possible to address AD by manipulating gut flora.

In summary, the gut microbiota emerges as both a perpetrator and protector which affects the onset and progression of AD through intricate processes involving neuroinflammatory pathways and the immune system. Therefore, this dual function supports the manipulation of the gut microbiota as an effective way for treatment strategies against AD, which involves either manipulating its composition to avoid harmful inflammatory responses or enhancing its protective actions against degeneration within neurons.

Citations:

Giau, V. V., Wu, S. Y., Jamerlan, A., An, S. S. A., Kim, S., & Hulme, J. (2018, November 14). Gut microbiota and their neuroinflammatory implications in Alzheimer's disease. MDPI. https://www.mdpi.com/2072-6643/10/11/1765 

Dissanayaka, D. M., Jayasena, V., Rainey-Smith, S. R., Martins, R. N., & Fernando, W. M. (2024). The role of diet and gut microbiota in alzheimer’s disease. Nutrients, 16(3), 412.https://doi.org/10.3390/nu16030412